Advances in genomics since the first full-length human DNA sequence was published over 15 years ago mean that we are now seeing many important clinical applications of this data-intense field. Many other ‘omic disciplines are also maturing to the point of clinical application (transcriptomics, proteomics, metabolomics, metagenomics). The rich molecular information yielded by ‘omics, when combined with relevant health information, has the potential to provide an unprecedented level of precision in the care we provide to our patients. We are at a shifting point in evidence-based medicine whereby we are increasingly relying on evidence from an individual, rather than evidence from an average of individuals.
Dr. Dan Muruve,
Vice Chair, Precision Medicine
Dr. Christina Hirota,
Personalized Medicine Project Coordinator